Our study also provides a potential explanation for the BET inhibitors’ sensitivity and suggests that the adjuvant treatment with autophagy inhibitors such as ubenimex to JQ1 may be better than JQ1 treatment alone in glioma cells. This evidence concerns the gene DNER and glioma.